Last updated at 31 Oct 2025 04:01 PM
Director
DIN: 10138550
Paramez Rajeev Ayyappath is currently associated with 2 companies as Director. They serve as a Director at GENIV HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10138550.Paramez Rajeev Ayyappath has previously been associated with 1 company in roles such as Additional Director.Paramez Rajeev Ayyappath is currently involved in 1 different role. Their most recent position is with UPFRONT ACADEMY PRIVATE LIMITED as a Director. The first company Paramez Rajeev Ayyappath was appointed to as a director was GENIV HEALTHCARE PRIVATE LIMITED. Paramez Rajeev Ayyappath is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Paramez Rajeev Ayyappath is currently associated with 2 companies as Director. They serve as a Director at GENIV HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10138550.Paramez Rajeev Ayyappath has previously been associated with 1 company in roles such as Additional Director.Paramez Rajeev Ayyappath is currently involved in 1 different role. Their most recent position is with UPFRONT ACADEMY PRIVATE LIMITED as a Director. The first company Paramez Rajeev Ayyappath was appointed to as a director was GENIV HEALTHCARE PRIVATE LIMITED. Paramez Rajeev Ayyappath is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
7 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GENIV HEALTHCARE PRIVATE LIMITED | Director | 31-Dec-2023 |
| UPFRONT ACADEMY PRIVATE LIMITED | Director | 24-Oct-2025 |